Understanding the Gap Between Guidelines and Influenza Vaccination Coverage in People With Diabetes: a Scoping Review
Source : https://pubmed.ncbi.nlm.nih.gov/38706547/
Influenza vaccination coverage in people with diabetes remains low despite recommendations and evidence on vaccine effectiveness. Motivators and barriers as well as several socio-demographic and clinical factors have been identified...
Determinants such as advanced age, presence of comorbidities and advice from healthcare professionals were associated with increased vaccination uptake.
A Review on Affordable Combinations in Type 2 Diabetes Care: Exploring the Cost-Effective Potential of Glipizide + Metformin and Glimepiride + Metformin + Pioglitazone
Management of type 2 diabetes mellitus (T2DM) largely relies on medication adherence of individuals with diabetes to achieve optimal glycemic control. The economic burden of diabetes could impede adherence, leading...
Affordable combination therapies can reduce medication costs by up to 20 times.
Making Treatment Guideline Recommendations in Chronic Kidney Disease and Type 2 Diabetes More Accessible to Primary Care Providers in the United States
Source : https://pubmed.ncbi.nlm.nih.gov/38712604/
Clinical practice guidelines for the management of chronic kidney disease (CKD) associated with type 2 diabetes (T2D) are designed to assist healthcare professionals with clinical decision making by providing recommendations...
Researchers explore reasons behind the low level of awareness and poor uptake of published evidence-based care approaches to the optimal care of patients with T2D and CKD.
With up to 23 years of follow-up of 3 large prospective cohorts of middle-aged and older men and women, self-reported melatonin supplement use was not associated with risk of type 2 diabetes or CVD.
Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People With Type 2 Diabetes
OBJECTIVE. To identify genetic risk factors for incident cardiovascular disease (CVD) among people with type 2 diabetes (T2D).RESEARCH DESIGN AND METHODS.
Researchers identified 3 novel genetic loci: rs147138607 (near CACNA1E/ZNF648), rs11444867 (near HS3ST1), and rs335407 (near TFB1M/NOX3).